Cannabis Policy
Oregon Regulator Recalls THC Extracts Due to Pesticide Concerns
The recall affects 9,300 product units that are still on the market and 13,600 units that were sold to consumers.
President Biden Signs Medical Cannabis Research Bill
Biden signed the bill on Friday, December 5, becoming the first US president to approve a cannabis-specific piece of legislation.
In Rhode Island, Recreational Cannabis Sales Begin
The first legal recreational cannabis products have been sold in Rhode Island.
In New York, 40% of Illicit Cannabis Products Contain Contaminants, Report Finds
In a new report published on November 30, local cannabis advocacy groups claim that many of these products are dangerous.
International Regulatory Developments For Key Psychedelics
Stephen Wright breaks down the lengthy process of getting a psychedelic medicine approved in the US.
Colorado Regulators Issue Warning About Moldy Cannabis Flower
State regulators in Colorado have issued another health and safety notice after “potentially unsafe levels” of total yeast and mold were found in a batch of cannabis flower.
Oregon’s Cannabis Regulator Adds a “Second Lab” Rule to Combat Lab Shopping
Cannabis companies in Oregon now face the possibility that their product samples may be sent to a second lab of the regulator’s choosing, so the product’s contents can be verified.
FDA Issues Warning Letters to Five CBD Companies
According to the administration, the products were marketed in a way that may have led consumers to purchase the items without realizing they contained CBD.
US Senate Passes Medical Cannabis Research Bill
The bill was passed by the US House of Representatives in July. It then went to the Senate, which passed it on Wednesday, November 16.
